Class I
Terminated
Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd, Noblesville, Indiana, NDC 45183-0014-69.
- Company
- Pharmakon Pharmaceuticals
- Recall Initiated
- March 26, 2014
- Posted
- June 18, 2014
- Recall Number
- D-1362-2014
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 80 syringes
- Firm Location
- Noblesville, IN, United States
Reason for Recall
Superpotent Drug: Product contains twice the stated amount of midazolam.
Distribution
IN
Lot / Code Info
Lot #: E1016227C, Exp. 4/21/2014; E0433735C, Exp. 4/20/2014
More recalls by Pharmakon Pharmaceuticals
Morphine Sulfate 0.5 mg/mL, Preservative Free in 0.9% Sodium Chloride, Rx, total volume 1 mL, This...
Jun 1, 2016 · Class I
Other recent Class I Drug recalls
UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactu...
Mckesson
· Feb 18, 2026
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLu...
Green Lumber Holdings, Llc
· Feb 11, 2026
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India...
Handelnine Global Llc
· Feb 11, 2026
ClearLife Allergy Nasal Spray, Extra Strength, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNat...
Medinatura New Mexico, Inc.
· Jan 14, 2026
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, L...
Fresenius Kabi Usa, Llc
· Dec 3, 2025